Kiniksa Pharmaceuticals International (KNSA) Asset Utilization Ratio (2022 - 2026)

Kiniksa Pharmaceuticals International's Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.95 for Q1 2026.

• Quarterly Asset Utilization Ratio rose 16.37% year-over-year to 0.95 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.95 (up 16.37% YoY) and the FY2025 annual result came in at 1.01, up 31.83% from the prior year.
• Asset Utilization Ratio was 0.95 for Q1 2026 at Kiniksa Pharmaceuticals International, up from 0.92 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.95 in Q1 2026 and bottomed at 0.02 in Q4 2022.
• A 5-year average of 0.54 and a median of 0.58 in 2024 frame the typical range for Asset Utilization Ratio.
• Peak annual rise in Asset Utilization Ratio reached 2362.26% in 2023, while the deepest fall reached 84.9% in 2023.
• Kiniksa Pharmaceuticals International's Asset Utilization Ratio stood at 0.02 in 2022, then surged by 2362.26% to 0.54 in 2023, then soared by 39.17% to 0.75 in 2024, then advanced by 23.2% to 0.92 in 2025, then advanced by 3.38% to 0.95 in 2026.
• Business Quant data shows KNSA's Asset Utilization Ratio at 0.95 in Q1 2026, 0.92 in Q4 2025, and 0.87 in Q3 2025.